BIO-key International (NASDAQ:BKYI – Get Free Report) issued its earnings results on Thursday. The technology company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.18), Zacks reports. BIO-key International had a negative return on equity of 3,124.77% and a negative net margin of 72.53%. The company had revenue of $1.46 million during the quarter, compared to the consensus estimate of $2.29 million.
BIO-key International Stock Performance
Shares of NASDAQ:BKYI opened at $0.86 on Friday. The company has a 50 day moving average of $1.22 and a 200 day moving average of $1.15. The company has a quick ratio of 0.71, a current ratio of 0.78 and a debt-to-equity ratio of 0.63. BIO-key International has a 12 month low of $0.52 and a 12 month high of $3.68.
About BIO-key International
Further Reading
- Five stocks we like better than BIO-key International
- How to Invest in Insurance Companies: A Guide
- Microsoft’s Big Malaysia Bet Could Pay Off for Investors
- What Investors Need to Know About Upcoming IPOs
- The 5 Most Oversold Stocks on the Market Are…
- How to Effectively Use the MarketBeat Ratings Screener
- Archer Aviation Stock Sees Surge in Institutional Buys
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.